Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
Date | Price Target | Rating | Analyst |
---|---|---|---|
9/30/2025 | $175.00 | Outperform | Evercore ISI |
9/23/2025 | $170.00 | Equal Weight → Overweight | Wells Fargo |
9/23/2025 | $165.00 | Hold → Buy | Melius |
9/19/2025 | $165.00 | Buy | Loop Capital |
9/16/2025 | $130.00 | Outperform | Raymond James |
9/16/2025 | $180.00 | Mkt Perform → Mkt Outperform | Citizens JMP |
8/27/2025 | $116.00 | Overweight | Cantor Fitzgerald |
8/21/2025 | $180.00 | Neutral → Buy | H.C. Wainwright |
4 - CoreWeave, Inc. (0001769628) (Issuer)
4 - CoreWeave, Inc. (0001769628) (Issuer)
4 - CoreWeave, Inc. (0001769628) (Issuer)
Evercore ISI initiated coverage of CoreWeave with a rating of Outperform and set a new price target of $175.00
Wells Fargo upgraded CoreWeave from Equal Weight to Overweight and set a new price target of $170.00
Melius upgraded CoreWeave from Hold to Buy and set a new price target of $165.00
SCHEDULE 13G/A - CoreWeave, Inc. (0001769628) (Subject)
8-K - CoreWeave, Inc. (0001769628) (Filer)
8-K - CoreWeave, Inc. (0001769628) (Filer)
In the news release, Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave, issued 17-Oct-2025 by Two Seas Capital over PR Newswire, three charts were inadvertently excluded by PR Newswire. The release, with the accompanying charts and the full pdf letter, follows: Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW
Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW YORK, Oct. 17, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today issued a letter to shareholders in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7, 2025.
Urges Core Scientific Stockholders to Vote FOR the Proposed Transaction CoreWeave Inc. (NASDAQ:CRWV), The Essential Cloud for AI, today released the following open letter to stockholders of Core Scientific, Inc. (NASDAQ:CORZ). The letter reaffirms CoreWeave's commitment to the proposed acquisition of Core Scientific on the previously agreed terms and corrects inaccurate and misleading statements made by Two Seas Capital ("Two Seas"), an event-driven hedge fund specializing in litigation. Dear Core Scientific Stockholders, CoreWeave entered into a definitive agreement to acquire Core Scientific in an all-stock transaction on July 7, 2025. This transaction represents the most compelling
4 - CoreWeave, Inc. (0001769628) (Issuer)
4 - CoreWeave, Inc. (0001769628) (Issuer)
In the news release, Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave, issued 17-Oct-2025 by Two Seas Capital over PR Newswire, three charts were inadvertently excluded by PR Newswire. The release, with the accompanying charts and the full pdf letter, follows: Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW
Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW YORK, Oct. 17, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today issued a letter to shareholders in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7, 2025.
CoreWeave (NASDAQ:CRWV), The Essential Cloud for AI, today announced the appointment of Jon Jones as its first Chief Revenue Officer (CRO). Jon Jones will lead the company's global revenue organization with a focus on scaling products and sales for the next chapter of CoreWeave's growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251016066234/en/Jon Jones, Chief Revenue Officer, CoreWeave A recognized AI industry leader, Jon Jones is a seasoned technology executive, with more than two decades of leadership experience during periods of major business expansion and transformation. A native of Silicon Valley, Jon Jones has held
CoreWeave, Inc. (NASDAQ:CRWV) announced today that it will release second quarter 2025 financial results, after the market closes on Tuesday, August 12, 2025. CoreWeave will also host a conference call to discuss its results at 2:00 pm Pacific Time / 5:00 pm Eastern Time. The live webcast of the earnings conference call can be accessed at the CoreWeave Investor Relations website at investors.coreweave.com. A replay of the webcast will be available at the same website. About CoreWeave, Inc. CoreWeave, the AI Hyperscaler™, delivers a cloud platform of cutting-edge software powering the next wave of AI. The company's technology provides enterprises and leading AI labs with cloud solution
Verticalizes Data Center Ownership to Help Future-Proof Revenue Growth and Enhance Core Profitability CoreWeave (NASDAQ:CRWV), the AI Hyperscaler™, and Core Scientific (NASDAQ:CORZ), a leading data center infrastructure provider, today announced that they have signed a definitive agreement under which CoreWeave will acquire Core Scientific in an all-stock transaction. Under the terms of the merger agreement, Core Scientific stockholders will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each share of Core Scientific common stock based on a fixed exchange ratio. Following CoreWeave's successful IPO in March 2025, this acquisition will help CoreWeave verticalize i
LIVINGSTON, N.J., April 25, 2025 /PRNewswire/ ---- CoreWeave, Inc. (NASDAQ:CRWV), the AI Hyperscaler™, announced that it will release first quarter 2025 financial results, after the market closes on Wednesday, May 14, 2025. CoreWeave will also host a conference call to discuss its results at 2:00 pm Pacific Time / 5:00 pm Eastern Time. The live webcast of the earnings conference call can be accessed at the CoreWeave Investor Relations website at investors.coreweave.com. A replay of the webcast will be available at the same website. About CoreWeave, Inc. CoreWeave, the AI Hyperscaler™, delivers a cloud platform of cutting-edge software powering the next wave of AI. The company's technology